Jason Bini 12 Jesus Mateo 13 Josef Machac 4 Jagat Narula 5 Valentin Fuster 35 Zahi Fayad 156 David IzquierdoGarcia 1 1 Translational and Molecular Imaging Institute Mount Sinai School of Medicine New York NY USA ID: 791596
Download The PPT/PDF document "Preclinical evaluation of MR-attenuation..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Preclinical evaluation of MR-attenuation correction versus CT-attenuation correction on the sequential whole-body MR/PET
Jason Bini1,2, Jesus Mateo1,3, Josef Machac4, Jagat Narula5, Valentin Fuster3,5, Zahi Fayad1,5,6 , David Izquierdo-Garcia1 1 Translational and Molecular Imaging Institute, Mount Sinai School of Medicine, New York, NY, USA2 The City College of New York, Department of Biomedical Engineering, New York, NY, USA 3 The Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid Spain4 Division of Nuclear Medicine, Department of Radiology, Mount Sinai School of Medicine., New York, NY, USA5 Department of Cardiology, Zena and Michael A Weiner Cardiovascular Institute and Marie-Josee and Henry R Kravis Cardiovascular Health Center., Mount Sinai School of Medicine, New York, NY, USA6 Department of Radiology, Mount Sinai School of Medicine, New York, NY, USA
Slide2Positron Emission
Tomography (PET)Functional imaging of physiologyHighly sensitive probes (10-12 Molar)Low spatial and anatomical resolutionAnatomical imaging from CT scanHigh spatial resolution anatomic imagingFunctional imaging possible but relatively low probe detection sensitivity (10-6 Molar)Magnetic Resonance Imaging (MRI)MR/PET
Slide3Many technical challenges to combine PET and MR
MR provides superior soft tissue contrast vs. CTMR/PET lower radiation dose to patient vs. PET/CTMR/PETCombined Sequential Whole-bodyPhilips Ingenuity TF sequential whole-body PET/MR system3T = 30000G3T MRI10G3m
PET
Slide4Attenuation Correction
CT to PET 511keV attenuation coefficient conversionPET/CT attenuation correction (AC)Clinical gold standardLow-dose CT scans easily transformed to attenuation map (CTAC) at 511 keV for use in PET reconstruction algorithms 1MRINo direct information about photon attenuationMeasures proton densities and magnetic relaxation timesMR-based AC (MRAC)Non-trivial method of assigning MR signal intensity to empircial photon attenuation coefficients in each voxel1 Burger C, et al. Eur J Nuc Med Mol Img. 2002;29(7):922–7.
Slide5Attenuation Correction
MR attenuation mapsCT attenuation mapsAttenuation correction implemented on Philips sequential whole-body MR/PETT1-wieghted MR acquisition that matches PET dimensionsSimilar to low-dose CT in PET/CTThree class segmentation algorithm following human-like a priori model (air, lungs and soft tissue)Animal imaging Lungs fail to segment - rabbit lung volumes do not match human-like a priori model2-segment classification (soft tissue and air)Soft tissue (0.095) 1,2 Air (0)
1
Meikle
SR,
et al
. JNM. 1993;34(1):143–50.
2
Bettinardi
V,
et al
.
Eur
J
Nuc
Med Mol
Img
. 1999;26(5):447–58.
Slide6MRAC vs. CTAC
Objective: Evaluate MRAC implemented on the combined sequential MR/PET scanner versus CTAC with the same PET data in an animal model
Slide7Animal Model
20 atherosclerotic New Zealand White male rabbits (3.8±0.3kg)Retrospectively analyzed 4-5 mCi injected of either… Fluoromisonidazole (18F-FMISO) (n=12) Fluorodeoxyglucose (18F-FDG) (n=8) CT acquisition Non-contrast low-dose CT Stand-alone CT scanner Philips Brilliance iCT -- 256 slice multidetector CT Voxel size 0.625x0.625x1.0mm Image matrix 512x512x399CT Imaging Protocol
Slide8PET Imaging Protocol
PET acquisition 3D mode Time of flight1 bed position/15 minutes – 3 hours post injection Images reconstructed into 128x128x90 matrix Voxel size 2x2x2mm 3D RAMLA reconstruction with 3 iterations and 33 subsets Philips system standard corrections Normalization, dead time, decay, scatter, random coincidences, sensitivity Attenuation correction provided by MRAC or CTAC methods No MR coils on table MR/PET table template inserted in reconstruction
Slide9PET Image Reconstruction
CTMRI CT and MR now both in PET spaceMR attenuation mapCT attenuation map - bilinear conversion to 511keV attenuation coefficients PET reconstruction
PET
CTAC
PET
MRAC
CT
coregsitered
to MR
Slide10MR attenuation map
CT attenuation mapPET with CTACPET with MRACPercent difference mapPercent difference map
Slide11PET quantification
voxel-by-voxelAverage difference for all voxels-0.94% (-0.06±0.30SD)R^2=0.99, p<0.0001
Slide12PET quantification
Regions-of-interest (ROIs)Six ROIsAorta, liver, left and right kidneys, spine and soft tissue (back muscles)Mean SUV ± Standard Deviation (SUVmin, SUVmax)ROIPET CTAC
PET
MRAC
p
AORTA
0.30
±0.22
(0.25, 0.37)
0.27
±0.22 (0.22, 0.35)
<0.0001
LIVER
1.06
±
0.68 (0.54, 1.40)
0.95
±
0.62 (0.47, 1.27)
<0.0001
LEFT KIDNEY
1.24
±
0.55 (0.34, 3.02)
1.12
±
0.48 (0.31, 2.47)
<0.0001
RIGHT KIDNEY
1.22
±
0.56 (0.31, 3.11)
1.14
±0.53 (0.30, 2.91)
<0.0001
SPINE
0.42
±
0.30 (0.21, 0.71)
0.31
±
0.25 (0.15, 0.54)
<0.0001
SOFT TISSUE
0.19
±
0.11 (0.13, 0.45)
0.16
±
0.10 (0.11, 0.38)
<0.0001
Slide13-9.7% (-0.15±0.12SD)
R^2=0.99, p<0.0001-10.8% (-0.08±0.06SD)R^2=0.99, p<0.0001PET quantificationRegions-of-interest (ROIs)
Slide14PET quantification
Regions-of-interest (ROIs)RabbitsPercent Difference SUVmeanPercent Difference SUVmaxALL
ROIs
ALL
-10.8
-9.7
FDG
-10.6
-10.4
FMISO
-11.0
-9.2
Aorta
ALL
-10.4
-7.6
FDG
-4.3
-2.6
FMISO
-21.2
-17.4
Liver
ALL
-10.4
-9.3
FDG
-9.5
-8.7
FMISO
-12.1
-10.3
Left
Kidney
ALL
-9.8
-9.5
FDG
-10.2
-10.1
FMISO
-9.5
-9.1
Right
Kidney
ALL
-6.2
-6.4
FDG
-7.2
-7.5
FMISO
-5.5
-5.8
Spine
ALL
-26.1
-23.6
FDG
-21.7
-19.5
FMISO
-35.5
-32.2
Soft
Tissue
ALL
-16.8
-15.5
FDG
-17.7
-17.4
FMISO
-15.8
-12.5
Rabbits
Percent Difference
SUVmean
Percent Difference
SUVmax
Slide15PET quantification
Regions-of-interest (ROIs)RabbitsAverageSUVmean
Absolute Difference
SUVmean
PET
CTAC
PET
MRAC
Left
Kidney
ALL
1.24
1.12
-0.12
FDG
1.26
1.13
-0.13
FMISO
1.23
1.12
-0.11
Right
Kidney
ALL
1.22
1.14
-0.08
FDG
1.16
1.08
-0.08
FMISO
1.25
1.19
-0.06
Spine
ALL
0.42
0.31
-0.11
FDG
0.72
0.57
-0.15
FMISO
0.22
0.14
-0.08
Soft
Tissue
ALL
0.20
0.16
-0.04
FDG
0.25
0.20
-0.05
FMISO
0.16
0.14
-0.02
Rabbits
Average
SUVmean
Absolute
Difference
SUVmean
PET
CTAC
PET
MRAC
ALL
ROIs
ALL
0.74
0.66
-0.08
FDG
0.94
0.84
-0.10
FMISO
0.61
0.54
-0.07
Aorta
ALL
0.30
0.27
-0.03
FDG
0.49
0.47
-0.02
FMISO
0.18
0.15
-0.03
Liver
ALL
1.07
0.95
-0.12
FDG
1.76
1.59
-0.17
FMISO
0.60
0.53
-0.07
Slide16Martinez-Möller
, et al 1Osseous lesions underestimated by 8.0% without bone segmentationHuman study - fat, soft-tissue, lungs and air segmentationPET/CT – CT map bone set to soft tissue attenuation coefficients of 0.10Hoffman, et al 2PET/CT with bone set to soft tissue (no reported soft tissue attenuation coefficient)Underestimation of 60% in spineKeereman, et al 3Human Whole-body MR/PET simulation studyTwo lesions in the spine underestimated by 11.7% and 10.8% (spongeous bone -> soft tissue) Same lesions underestimated by 15.6 and 17.5% (cortical bone ->soft tissue)Lesion in the pelvis underestimated by 13.1% (sponegous bone -> soft tissue)Soft tissue attenuation coefficient of 0.0968Steinberg, et al 4Underestimation in the spine of 14%Three segment classification, lung, soft tissue and air in beagles
Segmented MR with soft tissue attenuation coefficients of 0.098 coregistered
to PET/CT
Hu
,
et al
5
Human, three-region segmentation implemented on
Philips MR/PET scanner (15 patients)
Segmented MR
coregistered
with PET/CT
Underestimated lesions by 7.6% in spine and 11.7% in pelvis
In the context of the literature…
3
Keereman
V,
et al
. Med Phys. 2011;38(11):6010-9.
1
Martinez-
Möller
,
et al
. Journal of Nuclear Medicine. 2009;50(4):520–6
.
4
Steinberg J,
et al
. Nuclear medicine and biology. 2010;37(2):227–35.
5
Hu
Z,
et al
. Conference Record (NSS/MIC). 2009. p. 3508–12.
2
Hofmann M, et al.
Eur
J of
Nuc
Med Mol
Img
. 2009;36
Suppl
1:S93–104.
Slide17Wide range of underestimation differences in literature when ignoring bone (7 to 60%)
Results suggest the need for bone in MR attenuation maps to minimize quantification errorsAnimal model may impact degree of underestimation when bone is replaced with soft tissue due to percentage of total body volume that represents the skeleton1,2Ultrashort Echo Time (UTE) sequences for head and neck imagingNot solved for whole-body imagingLong acquisition timeDixon sequences to distinguish fat and soft tissue have been implemented for abdomen, head and neckLeft and right kidney discrepancyPETMRAC2 Keereman V, et al. Med Phys. 2011;38(11):6010-9. 1Steinberg J, et al. Nuclear medicine and biology. 2010;37(2):227–35.
Slide18We have confirmed the MR/PET sequential scanner underestimates PET values by <10% in most regions
Areas in or close to bone(spine and back muscles) underestimate values by >10%Despite underestimation, in and near bone, two segment classification of air and soft tissue for preclinical MRAC provides reasonable SUV quantification for sequential MR/PETPETMRAC
Slide19Acknowledgements
Cardio-Image Program from Centro Nacional de Investigaciones Cardiovasculares (CNIC), Spain (J.M., V.F.)Partial support was provided by NIH/NHLBI R01 HL071021, R01 HL078667 and NIH/NCRR CTSA UL1RR029887 (Imaging Core) (Z.A.F)